Rosiglitazone Inhibits Adrenocortical Cancer Cell Proliferation by Interfering with the IGF-IR Intra...
Rosiglitazone Inhibits Adrenocortical Cancer Cell Proliferation by Interfering with the IGF-IR Intracellular Signaling
About this item
Full title
Author / Creator
Publisher
United States: Hindawi Limiteds
Journal title
Language
English
Formats
Publication information
Publisher
United States: Hindawi Limiteds
Subjects
More information
Scope and Contents
Contents
Rosiglitazone (RGZ), a thiazolidinedione ligand of the peroxisome proliferator-activated receptor (PPAR)-γ, has been recently described as possessing antitumoral properties. We investigated RGZ effect on cell proliferation in two cell line models (SW13 and H295R) of human adrenocortical carcinoma (ACC) and its interaction with the signaling pathway...
Alternative Titles
Full title
Rosiglitazone Inhibits Adrenocortical Cancer Cell Proliferation by Interfering with the IGF-IR Intracellular Signaling
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_e516d14082104ec296040230e5f60ed0
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e516d14082104ec296040230e5f60ed0
Other Identifiers
ISSN
1687-4757
E-ISSN
1687-4765
DOI
10.1155/2008/904041
